Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 3, 2007, Pages 873-879

  Rickels, Michael R ^a   Schutta, Mark H ^a   Mueller, Rebecca ^a   Kapoor, Shiv ^a   Markmann, James F ^a   Naji, Ali ^a   Teff, Karen L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DACLIZUMAB; GLUCAGON; GROWTH HORMONE; HYDROCORTISONE; INSULIN; INSULIN GLARGINE; INSULIN LISPRO; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; CLAMP; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HORMONE ACTION; HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY ALLOGRAFT; MALE; MAXIMUM ALLOWABLE CONCENTRATION; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

EID: 33947509294     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2426     Document Type: Article

References (32)

1. Cryer PE, Davis SN, Shamoon H 2003 Hypoglycemia in diabetes. Diabetes Care 26:1902-1912
2. Gold AE, Macleod KM, Frier BM 1994 Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia. Diabetes Care 17:697-703
3. Cryer PE 2005 Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 54:3592-3601
4. Cryer PE 2004 Current concepts: diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350:2272-2279
5. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Divincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli GB 1993 Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42:1683-1689
6. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA 1994 Restoration of hypoglycemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 344:283-287
7. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Divincenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E, Perriello G, Defeo P, Santeusanio F, Brunetti P, Bolli GB 1994 Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycemia, following institution of rational, intensive insulin therapy in Iddm. Diabetologia 37:1265-1276
8. Dagogojack S, Rattarasarn C, Cryer PE 1994 Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 43:1426-1434
9. Liu DT, McManus RM, Ryan EA 1996 Improved counter-regulatory hormonal and symptomatic responses to hypoglycemia in patients with insulin-dependent diabetes mellitus after 3 months of less strict glycemic control. Clin Invest Med 19:71-82
10. Shapiro AMJ, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson P, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DER, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JRT 2006 International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355:1318-1330
11. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JRT, Shapir AMJ 2005 Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069
12. Kessler L, Passemard R, Oberholzer J, Benhamou PY, Bucher P, Toso C, Meyer P, Penfornis A, Badet L, Wolf P, Colin C, Morel P, Pinget M 2002 Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation. Diabetes Care 25:2256-2262
13. Geiger MC, Ferreira JV, Hafiz MM, Froud T, Baidal DA, Meneghini LF, Ricordi C, Alejandro R 2005 Evaluation of metabolic control using a continuous subcutaneous glucose monitoring system in patients with type 1 diabetes mellitus who achieved insulin independence after islet cell transplantation. Cell Transplantation 14:77-84
14. Paty BW, Senior PA, Lakey JR, Shapiro AM, Ryan EA 2006 Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects. Diabetes Technol Ther 8:165-173
15. Heller SR, Cryer PE 1991 Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 40:223-226
16. Rickels MR, Schutta MH, Mueller R, Markmann JF, Barker CF, Naji A, Teff KL 2005 Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes. Diabetes 54:3205-3211
17. Markmann JF, Deng S, Huang X, Desai NM, Velidedeoglu EH, Lui C, Frank A, Markmann E, Palanjian M, Brayman K, Wolf B, Bell E, Vitamaniuk M, Doliba N, Matschinsky F, Barker CF, Naji A 2003 Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 237:741-749
18. McGuire EA, Helderman JH, Tobin JD, Andres R, Berman M 1976 Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565-573
19. Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P, Gerich J 1991 Hierarchy of glycemic thresholds for counterregulatory hormone-secretion, symptoms, and cerebral-dysfunction. Am J Physiol 260:E67-E74
20. Defronzo RA, Tobin JD, Andres R 1979 Glucose clamp technique - method for quantifying insulin-secretion and resistance. Am J Physiol 237:E214-E223
21. Towler DA, Havlin CE, Craft S, Cryer P 1993 Mechanism of awareness of hypoglycemia - perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms. Diabetes 42:1791-1798
22. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, Divincenzo A, Annibale B, Lepore M, Lalli C, Delsindaco P, Brunetti P, Bolli GB 1994 Relative roles of insulin and hypoglycemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycemia in male and female humans. Diabetologia 37:797-807
23. Schwartz NS, Clutter WE, Shah SD, Cryer PE 1987 Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 79:777-781
24. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W 1995 Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 18:517-522
25. Meyer C, Hering BJ, Grossmann R, Brandhorst H, Brandhorst D, Gerich J, Federlin K, Bretzel RG 1998 Improved glucose counterregulation and autonomic symptoms after intraportal islet transplants alone in patients with long-standing type I diabetes mellitus. Transplantation 66:233-240
26. Paty BW, Ryan EA, Shapiro AMJ, Lakey JRT, Robertson RP 2002 Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes 51:3428-3434
27. Hoeldtke RD, Boden G, Shuman CR, Owen OE 1982 Reduced epinephrine secretion and hypoglycemia unawareness in diabetic autonomic neuropathy. Ann Intern Med 96:459-462
28. Meyer C, Grossmann R, Mitrakou A, Mahler R, Veneman T, Gerich J, Bretzel RG1998 Effects of autonomic neuropathy on counterregulation and awareness at hypoglycemia in type 1 diabetic patients. Diabetes Care 21:1960-1966
29. Kendall DM, Rooney DP, Smets YFC, Bolding LS, Robertson RP 1997 Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes 46:249-257
30. Paty BW, Lanz K, Kendall DM, Sutherland DER, Robertson RP 2001 Restored hypoglycemic counterregulation is stable in successful pancreas transplant recipients for up to 19 years after transplantation. Transplantation 72:1103-1107
31. Defeo P, Perriello G, Torlone E, Ventura MM, Santeusanio F, Brunetti P, Gerich JE, Bolli GB 1989 Demonstration of a role for growth-hormone in glucose counterregulation. Am J Physiol 256:E835-E843
32. Rizza RA, Cryer PE, Gerich JE 1979 Role of glucagon, catecholamines, and growth-hormone in human glucose counter-regulation - effects of somatostatin and combined α-adrenergic and β-adrenergic-blockade on plasma-glucose recovery and glucose flux rates after insulin-induced hypoglycemia. J Clin Invest 64:62-71